Key takeaways
- • Severity: Major — avoid or close monitoring.
- • Wegovy (weight management (FDA-approved obesity)) and Insulin Glargine (Lantus) (Long-acting basal insulin (diabetes)).
- • Clinical management: Insulin dose is typically reduced when starting or escalating semaglutide. All dosing decisions should be made by the prescriber.
- • Monitoring: More frequent fingerstick or CGM glucose monitoring during initiation and dose escalation; periodic A1c.
Mechanism
Concomitant use of semaglutide with basal insulin produces additive glucose-lowering effects, materially increasing the risk of hypoglycemia. The risk is dose-dependent and most pronounced during semaglutide titration when insulin doses have not yet been adjusted downward.
Clinical management
Insulin dose is typically reduced when starting or escalating semaglutide. All dosing decisions should be made by the prescriber.
GLP1Zoom does not prescribe medications or recommend dose changes. Always confirm any adjustment with your prescribing clinician before changing how you take Wegovy or Insulin Glargine (Lantus).
Monitoring
More frequent fingerstick or CGM glucose monitoring during initiation and dose escalation; periodic A1c.
When to call your doctor
- shakiness, sweating, confusion, palpitations
- loss of consciousness or seizure
- repeated low glucose readings
In emergencies — severe abdominal pain, persistent vomiting, fainting, signs of severe hypoglycemia (confusion, seizures), or signs of bleeding — call 911 or go to the nearest emergency department.
Source / FDA label citation
Ozempic and Wegovy USPI Warnings and Precautions discuss hypoglycemia risk with concomitant insulin or insulin secretagogues.
Editorial confidence: 10/10. Lower scores reflect inferred mechanism rather than directly-labeled interaction. We re-verify against the active FDA prescribing information at least every 6 months.
Common questions
Can I take Insulin Glargine (Lantus) with Wegovy?
High clinical risk — discuss with your prescriber before combining. Insulin dose is typically reduced when starting or escalating semaglutide. All dosing decisions should be made by the prescriber. Always confirm the specific plan with your prescriber — this page summarizes general pharmacology, not personal medical advice.
What's the mechanism of any Wegovy + Insulin Glargine (Lantus) interaction?
Concomitant use of semaglutide with basal insulin produces additive glucose-lowering effects, materially increasing the risk of hypoglycemia. The risk is dose-dependent and most pronounced during semaglutide titration when insulin doses have not yet been adjusted downward.
What should I monitor when on Wegovy + Insulin Glargine (Lantus)?
More frequent fingerstick or CGM glucose monitoring during initiation and dose escalation; periodic A1c.
When should I call my doctor?
Contact your prescriber if you notice any of: shakiness, sweating, confusion, palpitations; loss of consciousness or seizure; repeated low glucose readings.
Related
This page summarizes general pharmacology from FDA-approved prescribing information. It is not a substitute for personalized medical advice. GLP1Zoom is an affiliate-only comparator — we do not prescribe or sell medications. Full disclaimer.